Live webcast on Thursday, December 12th at 4:00 PM ET LA JOLLA, CA, Dec. 06, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing...
Workshop, poster and oral presentation of data given as part of the 8th Annual Antifibrotic Drug Development (AFDD) Summit Data demonstrate that NKT cells are activated in airways in IPF patients...
$13.9 million in gross proceeds raised since the beginning of 2024 extending expected cash runway into mid Q1 2025 and through interim data readout from GRI-0621 Phase 2a biomarker study Topline...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.17701 | 26.4194029851 | 0.67 | 0.995 | 0.6694 | 774620 | 0.87150688 | CS |
4 | 0.126 | 17.4754857769 | 0.72101 | 0.995 | 0.6113 | 400932 | 0.78731361 | CS |
12 | 0.38761 | 84.3730953418 | 0.4594 | 1.79 | 0.3015 | 4725192 | 0.9830988 | CS |
26 | -2.53299 | -74.9405325444 | 3.38 | 3.4905 | 0.3015 | 2531098 | 1.03588244 | CS |
52 | -34.18799 | -97.5823890395 | 35.035 | 65 | 0.3015 | 1548098 | 3.84027961 | CS |
156 | -1200.35299 | -99.929486347 | 1201.2 | 1213.03 | 0.3015 | 1025312 | 12.16626561 | CS |
260 | -1200.35299 | -99.929486347 | 1201.2 | 1213.03 | 0.3015 | 1025312 | 12.16626561 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales